Susan Henry, former dean of the College of Agriculture and Life Sciences and a molecular geneticist whose breakthroughs in understanding cell metabolism contributed to advances in human pharmaceuticals, died March 7 at age 79.
Researchers at Cornell's Weill Institute for Cell and Molecular Biology have uncovered new evidence that two major types of gene-controlling DNA sequences, promoters and enhancers, operate with a shared logic and often perform the same jobs.
Cornell researchers have uncovered a built-in molecular “gate” that controls the production of the molecule nitric oxide, a crucial signaling molecule throughout biology that in humans helps regulate blood pressure, brain signaling, and immune defenses. But when levels go unchecked, it can damage cells and disrupt normal signaling.
Cornell's Integrated Pest Management program is now in its fourth decade, growing from an effort to reduce pesticide use in agriculture into a statewide model for science-based, economically beneficial pest control to protect crops, public health and the environment.
In June 2023, smoke from Canadian wildfires dampened birds’ vocalizations in New York state, with a particularly negative effect on already imperiled grassland birds.
Immunotherapy has not worked well against fibrolamellar carcinoma, but a new study finds an existing FDA-approved drug may allow the treatment to fight the cancer as intended.
Cornell researchers have discovered a new way cells regulate how they respond to stress, identifying an interaction between two proteins that helps keep a critical cellular recycling system in balance.
The study from an international team of experts in veterinary medicine, human medicine and genomics provides the first large-scale genetic map of feline cancer.